Use of growth hormone for prevention or treatment of effects of aging (Q35860335)

10 August 2017

1 reference

title

Use of growth hormone for prevention or treatment of effects of aging (English)

1 reference

10 August 2017

S Mitchell Harman

1

1 reference

10 August 2017

Marc R Blackman

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

The Journals of Gerontology

10 August 2017

published in

1 reference

10 August 2017

volume

59

1 reference

10 August 2017

issue

7

1 reference

10 August 2017

page(s)

652-658

1 reference

Neuroendocrine aging in men. Andropause and somatopause

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Gonadotropin Secretion during Aging in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Theoretical basis for the benefit of postmenopausal estrogen substitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Involutional osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Insulin resistance and fat patterning with aging: relationship to metabolic risk factors for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Body size and fat distribution as predictors of stroke among US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Predictors of lean body mass and total adipose mass in community-dwelling elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Two years of replacement therapy in adults with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Growth hormone therapy in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Growth hormone therapy and fracture risk in the growth hormone-deficient adult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Effects of growth hormone replacement on physical performance and body composition in GH deficient adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Effects of human growth hormone in men over 60 years old

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Growth hormone - hormone replacement for the somatopause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

The safety profile of GH replacement therapy in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Heart muscle disease in acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Cardiovascular effects of short-term growth hormone hypersecretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Epidemiology of acromegaly in the Newcastle region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Factors influencing the desire for long-term growth hormone replacement in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Growth hormone replacement in healthy older men improves body composition but not functional ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Peripheral glucose metabolism in acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Acromegaly and the risk of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Risk of leukemia in children treated with human growth hormone: review and reanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Growth factors, apoptosis, and survival of mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Effects of long-term elevated serum levels of growth hormone on life expectancy of mice: Lessons from transgenic animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Prolonged longevity of hypopituitary dwarf mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Reduced longevity in untreated patients with isolated growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Aspects of growth hormone (GH) replacement in elderly patients with GH deficiency: data from KIMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.7.B652

21 January 2018

Identifiers

DOI

10.1093/GERONA/59.7.B652

1 reference

10 August 2017

1 reference